Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 167 results for "Suboxone Tablets"

New and Generic Drug Approvals: Suboxone

SUBOXONE BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE EQ 2MG BASE; EQ 0.5MG BASE TABLET;SUBLINGUAL Discontinued No ... U.S. Food and Drug Administration, 2 weeks ago

3 images for "Suboxone Tablets"

CNN, 2 weeks ago
CNN Money, 1 month ago
Irish Examiner, 6 months ago
Irish Times

Methadone alternative to be made available to drug addicts

Introduction of Suboxone delayed because of need for specific legislation An alternative to methadone for treating people with heroin and other opiate drug addictions is to be made widely available after the Department of Health agreed to provide ...
 Irish Times1 month ago

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed analysis on Technologies and Pipeline Development

Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeable. The buccal mucosa offers several advantages for controlled ...
 MyNewsDesk2 weeks ago
Investing.com

Mundipharma obtains global ex-US rights to Zubsolv

Mundipharma has obtained exclusive global (ex-US) rights to Orexo's Zubsolv (buprenorphine and naloxone sublingual tablet), a potential new treatment option for patients outside the US with opioid dependence. Under the terms of the agreement, Orexo ...
 European Pharmaceutical Review3 weeks ago OREXO : Mundipharma obtains global ex-US rights to Zubsolv  4 Traders3 weeks ago Orexo: Mundipharma To Take Zubsolv Global  Investing.com3 weeks ago Mundipharma AG Obtains Global (Ex-US) Rights To Orexo???s Opioid Dependence Treatment Zubsolv (Buprenorphine And Naloxone)  BioSpace3 weeks ago
[x]  

Indivior PLC Intention to List ADRs in U.S.

15/07/2016 6:00am UK Regulatory (RNS & others) Indivior (LSE:INDV) Intraday Stock Chart Today : Friday 15 July 2016 TIDMINDV RNS Number : 2566E Indivior PLC 15 July 2016 Indivior Announces Intention to List ADRs in U.S. ...
 ADVFN UK1 week ago Intention to List ADRs in U.S.  MoneyAM1 week ago Indivior PLC Indivior welcomes Court ruling in ANDA litigation  ADVFN UK1 month ago Indivior welcomes Court ruling in ANDA litigation  London Stock Exchange1 month ago

Indivior Applauds Congressional Passage of Bipartisan Comprehensive Addiction & Recovery Act of 2016 (CARA)

/PRNewswire/ -- Indivior PLC (LON: INDV) commends the United States Senate and House of Representatives for their leadership in passing the Comprehensive Addiction & Recovery Act of 2016 (CARA), S. 524. This bipartisan legislation signals a strong ...
 Nasdaq2 weeks ago
[x]  

IntelGenx Technologies Corp. (IGXT: OTCQX U.S.) | IntelGenx Announces Notice of Appeal for Buprenorphine/Naloxone Sublingual Film Product for the Treatment of Opiate Addiction

) - IntelGenx Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the receipt of the recent notice of appeal for the buprenorphine/naloxone sublingual film product for the treatment of opiate addiction by Par Pharmaceutical, Inc. and IntelGenx ...
 OTC Markets2 weeks ago INTELGENX TECHNOLOGIES : Announces Notice of Appeal for Buprenorphine/Naloxone Sublingual Film Product for the Treatment of Opiate Addiction  4 Traders2 weeks ago INTELGENX ANNOUNCES NOTICE OF APPEAL FOR BUPRENORPHINE AND NALOXONE SUBLINGUAL FILM PRODUCT FOR THE TREATMENT OF OPIATE ADDICTION  Pharmacy Choice2 weeks ago
[x]  

INDIVIOR PLC SPON ADR EA REPR 5 (INVVY) Upgraded to Hold at Zacks Investment Research

INDIVIOR PLC SPON ADR EA REPR 5 (NASDAQ:INVVY) was upgraded by Zacks Investment Research from a strong sell rating to a hold rating in a note issued to investors on Friday. According to Zacks, Indivior PLC operates as a specialty pharmaceutical ...
 WKRB News2 weeks ago
[x]  

Mundipharma and Orexo to launch opioid dependence treatment Zubsolv outside US

Mundipharma has signed an agreement with Swedish-based pharmaceutical company Orexo to grant exclusive global (ex-US) rights to Mundipharma's network of independent associated companies for Zubsolv (buprenorphine and naloxone sublingual tablet), for ...
 Pharmaceutical Technology3 weeks ago
Christian Science Monitor

How Canada's Blood Tribe brought opiate overdose deaths down to zero

After a year which saw 35 people die from using opiates, the Albertan reserve has shown how a community can rally against drug abuse in the face of immense hurdles and historical trauma. Gayle Chase holds a smudge box, used in Blackfoot tradition to ...
 Christian Science Monitor3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less